Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Dabrowa Gornicza – page 2

16 clinical trials in Dabrowa Gornicza, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Dabrowa Gornicza at a glance
16
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

16 trials in Dabrowa Gornicza

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Jtt-861 Monohydrochloride Dihydrate
  • Sponsor:Akros Pharma Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bi 765845
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Dabrowa Gornicza

What the registry says about research in the country

01 Heart Failure Research

Innovative studies focusing on SGLT-2 inhibitors for patients with acute heart failure, examining treatment effectiveness across different ejection fraction types.

  • Acute/decompensated heart failure
  • Treatment optimization
  • Clinical outcomes improvement

Research aims to enhance patient care regardless of diabetes status.

02 Cardiovascular Disease Prevention

Advanced trials investigating novel therapies for atherosclerotic cardiovascular disease, focusing on preventing major adverse cardiovascular events.

  • Heart attack prevention
  • Stroke prevention
  • Vascular disease management

Studies evaluate innovative compounds to reduce cardiovascular risks in high-risk populations.

03 Acute Coronary Care

Comprehensive research on acute coronary syndrome treatments, including antiplatelet therapy strategies and metabolic interventions.

  • Coronary revascularization
  • Antiplatelet therapy
  • Post-intervention care

Trials focus on optimizing treatment approaches for better patient outcomes.

04 Cardiac Rhythm Management

Studies examining new treatments for atrial fibrillation, comparing novel anticoagulants with established therapies for safety and effectiveness.

  • Bleeding risk management
  • Anticoagulation therapy
  • Heart rate control

Research aims to improve safety profiles of cardiac rhythm treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.